To compare healthcare utilization outcomes for patients adding cenobamate or 7 other newer antiseizure medications (ASMs) to existing therapy regimens following surgical or neurostimulation therapy for seizure disorders.
No takes yet. Share an insight, caveat, or question.
Pellinen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: